Intendis GmbH
Records under this name other than patents Intendis GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Intendis GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,986,658 | Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,731,021 | Hydrogel composition for the treatment of dermatological disorders Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,658,138 | Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 6,534,070 | Composition with azelaic acid Formerly held Term ended Term ended Aug 21, 2020 · From the USPTO record | Term ended | Term ended Aug 21, 2020 | From the USPTO record |
| US 8,071,796 | Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof Lapsed on the fee record Ended Dec 6, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 6, 2019 | From the USPTO record |
| US 8,282,909 | Pharmaceutical composition for topical application of poorly soluble compounds Lapsed on the fee record Ended Oct 9, 2016 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2016 | From the USPTO record |
| US 5,583,125 | 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents Term ended Term ended no later than Dec 10, 2016 · Low confidence | Term ended | Term ended no later than Dec 10, 2016 | Low confidence |